These studies confirm previously published results in pancreatic ductal adenocarcinoma cells35 and in gastric cancer cells34, that reduced levels of endogenous TRPM2 can down modulate migration and invasion. The gene discussed is TRPM2; the disease is pancreatic ductal adenocarcinoma.